The CTT story (2008-2018): 10 years of hopes and activities
The general idea and foundation of our Cellular Therapy and Transplantation Journal (CTT) were based on a long-term cooperation between Russian and European specialists in the area of bone marrow transplantation (BMT). Common studies in adjacent research topics stemmed from previous contacts between the Russian and European hematologists, oncologists, and experts in the fi eld of molecular biology and gene therapy since 1990s. In view of close working contacts between the clinicians from diff erent countries, and training programs for young Russian specialists in foreign clinics, a need for a special international edition for better cooperation was recognized by Prof. Boris V. Afanasyev, Prof. G. Wagemaker, Prof. Axel R. Zander and other prominent workers in the fi eld. The general concept of Cellular Therapy and Transplantation was elaborated during discussions at the Wilsede and EBMT Meetings in 2006-2008.
Therefore, the pilot CTT issue appeared online in June 2008, preceded by a foreword by Mr. Michael Gorbachev, the former Russian President who expressed his best wishes to the CTT Journal. Over 2000s Michael Gorbachev contributed much to development of BMT in Russia, by funding and construction of the R. M. Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation which was opened at the St. Petersburg State I. Pavlov Medical University in September 2007. Hence, the CTT Journal proved to be a suffi cient part of a big program aimed for development of hematopoietic transplantation in Russia and ex-USSR countries, and exchange of useful data with our Western colleagues. The CTT publications provided additional valuable knowledge for the young specialists from Russia, increased their motivation, and improved language skills when preparing their articles in English. The CTT articles also facilitated their Ph.D. defense.
Since launching the CTT Journal, its general editorial policy was to publish competent opinions, as well as modern clinical and research results obtained by Russian and Western clinicians and researchers. Then and now, we accept articles written in English language with extended Russian summaries, thus attracting authors and readership of both ex-USSR and Western countries.
Over these years, we have been proud of publishing some historical notes about A. A. Maximov, and A. Ya. Friedenstein and their innovative ideas in hematology, a number of comprehensive reviews on the BMT techniques, treatment regimens and novel curative drugs which increase therapeutic efficiency and improve quality of life in the patients, as well as a number of original articles. Every year, CTT publishes the abstracts of presentations and short reports from the R. Gorbacheva Memorial Symposium dedicated to hematopoietic stem cell transplantation. The CTT Journal is referred in Russian and Western databases (Scopus, Research-Gate, Google Scholar, E-library), being approved by the Russian State Commission for Academic Degrees and Titles.
Our Editorial Board is presented by the well-known specialists in BMT and related topics from diff erent countries. A special gratitude should be expressed to Professor Axel R. Zander, Prof. Gerard Wagemaker, and Prof. Boris Fehse for their long-range participation in our cooperation and the CTT editorial activities. We hope that the general policy and content of the Journal will retain, thus further promoting dissipation of transplantation science and improving knowledge in cell therapy in Russian and European clinics, especially, modern technologies, including gene therapy, for the sake of patients with oncohematological diseases and inherited disorders.